drugset / Trial / NCT04528056
Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Under placebo control, the investigators intend to evaluate the effectiveness and safety of anti-inflammatory therapy and/or targeted drug therapy for early treatment of patients with pulmonary arterial hypertension.
Timeline
- Start
- 2020-08-01
- Primary completion
- 2021-12-31
- Completion
- 2022-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ambrisentan | Small molecule | — | — |
| Subject | Sulfasalazine | Small molecule | — | — |